Company registration number 07496674 (England and Wales)
THE SOUND DOCTOR LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
THE SOUND DOCTOR LIMITED
CONTENTS
Page
Statement of financial position
1 - 2
Notes to the financial statements
3 - 7
THE SOUND DOCTOR LIMITED
STATEMENT OF FINANCIAL POSITION
AS AT
31 MARCH 2025
31 March 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Intangible assets
3
272,600
313,617
Tangible assets
4
78
146
Investments
5
-
0
244
272,678
314,007
Current assets
Debtors
6
142,167
67,209
Cash at bank and in hand
61,234
9,201
203,401
76,410
Creditors: amounts falling due within one year
7
(137,781)
(95,530)
Net current assets/(liabilities)
65,620
(19,120)
Total assets less current liabilities
338,298
294,887
Creditors: amounts falling due after more than one year
8
(17,231)
(20,864)
Provisions for liabilities
(20)
(37)
Net assets
321,047
273,986
Capital and reserves
Called up share capital
1,002
1,002
Share premium account
318,416
318,416
Profit and loss reserves
1,629
(45,432)
Total equity
321,047
273,986
THE SOUND DOCTOR LIMITED
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT
31 MARCH 2025
31 March 2025
- 2 -

For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the income statement within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 23 December 2025 and are signed on its behalf by:
Mr D G P Arkwright
Mrs R A Arkwright
Director
Director
Company registration number 07496674 (England and Wales)
THE SOUND DOCTOR LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 3 -
1
Accounting policies
Company information

The Sound Doctor Limited is a private company limited by shares incorporated in England and Wales. The registered office is Ranbury Farmhouse, London Road, Poulton, Gloucestershire, GL7 5HN.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

1.2
Revenue

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

 

When cash inflows are deferred and represent a financing arrangement, the promised consideration is adjusted for the effects of the time value of money, which is recognised as interest income.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.3
Intangible fixed assets other than goodwill

Intangible assets acquired separately from a business are recognised at cost and are subsequently measured at cost less accumulated amortisation and accumulated impairment losses.

 

Intangible assets acquired on business combinations are recognised separately from goodwill at the acquisition date where it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the fair value of the asset can be measured reliably; the intangible asset arises from contractual or other legal rights; and the intangible asset is separable from the entity.

Amortisation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Development costs
Amortised evenly over their estimated useful life of ten years
1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and machinery
25% on cost
1.5
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

THE SOUND DOCTOR LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 4 -
Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the income statement because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the income statement, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
2
2
THE SOUND DOCTOR LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 5 -
3
Intangible fixed assets
Other
£
Cost
At 1 April 2024
643,292
Additions
7,661
At 31 March 2025
650,953
Amortisation and impairment
At 1 April 2024
329,675
Amortisation charged for the year
48,678
At 31 March 2025
378,353
Carrying amount
At 31 March 2025
272,600
At 31 March 2024
313,617
4
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 April 2024 and 31 March 2025
15,923
Depreciation and impairment
At 1 April 2024
15,777
Depreciation charged in the year
68
At 31 March 2025
15,845
Carrying amount
At 31 March 2025
78
At 31 March 2024
146
5
Fixed asset investments
2025
2024
£
£
Shares in group undertakings and participating interests
-
0
244

During the period, the investment held in Team Doctor Limited has been written off following its dissolution.

THE SOUND DOCTOR LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
5
Fixed asset investments
(Continued)
- 6 -
Movements in fixed asset investments
Shares in associates
£
Cost or valuation
At 1 April 2024 & 31 March 2025
244
Impairment
At 1 April 2024
-
Disposals
244
At 31 March 2025
244
Carrying amount
At 31 March 2025
-
At 31 March 2024
244
6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
6,001
3,280
Other debtors
136,166
63,929
142,167
67,209
7
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans and overdrafts
6,967
28,457
Trade creditors
-
0
213
Corporation tax
62,599
30,013
Other taxation and social security
26,465
21,552
Other creditors
41,750
15,295
137,781
95,530
8
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans and overdrafts
17,231
20,864
THE SOUND DOCTOR LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 7 -
9
Directors' transactions

Dividends totalling £0 (2024 - £0) were paid in the year in respect of shares held by the company's directors.

Loans
% Rate
Opening balance
Amounts advanced
Interest charged
Amounts repaid
Closing balance
£
£
£
£
£
Mr D G P Arkwright & Mrs R A Arkwright
2.25
44,989
103,444
2,565
(52,118)
98,880
44,989
103,444
2,565
(52,118)
98,880
2025-03-312024-04-01falsefalsefalse23 December 2025CCH SoftwareCCH Accounts Production 2025.300No description of principal activityMr D G P ArkwrightMrs R A Arkwright074966742024-04-012025-03-31074966742025-03-31074966742024-03-3107496674core:IntangibleAssetsOtherThanGoodwill2025-03-3107496674core:IntangibleAssetsOtherThanGoodwill2024-03-3107496674core:OtherPropertyPlantEquipment2025-03-3107496674core:OtherPropertyPlantEquipment2024-03-3107496674core:CurrentFinancialInstrumentscore:WithinOneYear2025-03-3107496674core:CurrentFinancialInstrumentscore:WithinOneYear2024-03-3107496674core:CurrentFinancialInstruments2025-03-3107496674core:CurrentFinancialInstruments2024-03-3107496674core:Non-currentFinancialInstruments2025-03-3107496674core:Non-currentFinancialInstruments2024-03-3107496674core:ShareCapital2025-03-3107496674core:ShareCapital2024-03-3107496674core:SharePremium2025-03-3107496674core:SharePremium2024-03-3107496674core:RetainedEarningsAccumulatedLosses2025-03-3107496674core:RetainedEarningsAccumulatedLosses2024-03-3107496674bus:Director12024-04-012025-03-3107496674bus:Director22024-04-012025-03-3107496674core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3107496674core:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-04-012025-03-3107496674core:FurnitureFittings2024-04-012025-03-31074966742023-04-012024-03-3107496674core:IntangibleAssetsOtherThanGoodwill2024-03-3107496674core:OtherPropertyPlantEquipment2024-03-3107496674core:OtherPropertyPlantEquipment2024-04-012025-03-3107496674bus:PrivateLimitedCompanyLtd2024-04-012025-03-3107496674bus:SmallCompaniesRegimeForAccounts2024-04-012025-03-3107496674bus:FRS1022024-04-012025-03-3107496674bus:AuditExemptWithAccountantsReport2024-04-012025-03-3107496674bus:FullAccounts2024-04-012025-03-31xbrli:purexbrli:sharesiso4217:GBP